The factors expected to drive market growth are an increase in the prevalence of high blood pressure (hypertension), an increase in the geriatric population, and an increase in government initiatives to raise awareness about blood pressure diseases. For example, in May 2017, the Argentinian Society of Hypertension (SAHA) participated in campaigns such as "May Measurement Month & World Hypertension Day" to raise public awareness about hypertension and its management. Furthermore, an increase in marketing approvals for generic versions of Telmisartan Market, an increase in sedentary lifestyle, and an increase in the incidences of chronic diseases such as diabetes and kidney disease are expected to drive the growth of the telmisartan market. However, drug shortages are expected to limit the growth of the telmisartan market.
Read More @ https://cmiinfonest.blogspot.com/2023/02/the-global-telmisartan-market-is.html
